USE OF CAV3.1 SELECTIVE T-TYPE CALCIUM CHANNEL ANTAGONISTS

摘要

The present invention is directed to heterocyclic compounds which are antagonists of T-type calcium channels and which are useful in the treatment and prevention of disorders and diseases in which T-type calcium channels are involved. The invention is also directed to methods of identifying a compound for the treatment and prevention of Alzheimer's Disease by investigating T-type calcium channel blocking activity of the compound.